Fulgent Genetics Share Price (NASDAQ: FLGT)

$21.65

▲

0.39

(1.83%)

Live

Last updated on August 18, 2025 at 11:40 PM IST

$₹

Check the interactive Fulgent Genetics Stock chart to analyse performance

Fulgent Genetics stock performance

as on August 18, 2025 at 11:40 PM IST

Today's Low:$21.45
Today's High:$21.65
$21.65
0.92%
Downside
Day's Volatility :0.92%
Upside
0.0%
52 Weeks Low:$14.57
52 Weeks High:$23.99
$21.65
32.7%
Downside
52 Weeks Volatility :39.26%
Upside
9.74%

Fulgent Genetics Stock Returns

Period	Fulgent Genetics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	0.19%	2.3%	0.0%
6 Months	25.95%	-5.8%	0.0%
1 Year	-10.67%	-10.9%	0.0%
3 Years	-56.61%	2.8%	-11.6%

Fulgent Genetics Inc Key Stats

Check Fulgent Genetics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$21.26
Open	$21.845
Today's High	$21.65
Today's Low	$21.45
Market Capitalization	$666.4M
Today's Volume	$256.9K
52 Week High	$23.9868
52 Week Low	$14.57
Revenue TTM	$303.2M
EBITDA	$-48.6M
Earnings Per Share (EPS)	$-1.66
Profit Margin	-16.83%
Quarterly Earnings Growth YOY	-0.99%
Return On Equity TTM	-4.65%

Stock Returns calculator for Fulgent Genetics Stock including INR - Dollar returns

The Fulgent Genetics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Fulgent Genetics investment value today

Current value as on today

₹95,040

Returns

₹4,960

(-4.96%)

Returns from Fulgent Genetics Stock

₹9,034 (-9.03%)

Dollar Returns*

₹4,073 (+4.07%)

Indian investors sentiment towards Fulgent Genetics Stock

1300%

Period: Jul 18, 2025 to Aug 17, 2025. Change in 30 Days versus previous period

Search interest for Fulgent Genetics Stock from India on INDmoney has increased by 1300% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Fulgent Genetics Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
7.33%
Millennium Management LLC
6.43%
Vanguard Group Inc
3.82%
Dimensional Fund Advisors, Inc.
3.36%
Acadian Asset Management LLC
2.63%
Ameriprise Financial Inc
2.04%

Analyst Recommendation on Fulgent Genetics Stock

Rating

Trend

Buy

66%Buy

33%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Fulgent Genetics(by analysts ranked 0 to 5 stars)

Fulgent Genetics Share Price Target

What analysts predicted

Upside of 17.01%

Target:

$25.33

Current:

$21.65

Fulgent Genetics share price target is $25.33, a slight Upside of 17.01% compared to current price of $21.65 as per analysts' prediction.

Fulgent Genetics Stock Insights

Price Movement
In the last 1 month, FLGT stock has moved up by 19.6%
Increasing Revenue
Revenue is up for the last 2 quarters, 73.46M → 81.80M (in $), with an average increase of 10.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -5.88M → -18.95M (in $), with an average decrease of 80.1% per quarter
FLGT vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 32.2% return, outperforming this stock by 41.7%
FLGT vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 73.7% return, outperforming this stock by 130.8%
Price to Sales
ForFLGT every $1 of sales, investors are willing to pay $2.2, whereas for Idexx Laboratories, Inc., the investors are paying $13.1 for every $1 of sales.

Fulgent Genetics Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$32.5M	↑ 52.31%
Net Income	$366.0K	↓ 108.15%
Net Profit Margin	1.13%	↑ 22.15%

	FY20	Y/Y Change
Revenue	$421.7M	↑ 1196.46%
Net Income	$214.3M	↑ 58454.64%
Net Profit Margin	50.82%	↑ 49.69%

	FY21	Y/Y Change
Revenue	$992.6M	↑ 135.37%
Net Income	$104.3M	↓ 51.31%
Net Profit Margin	10.51%	↓ 40.31%

	FY22	Y/Y Change
Revenue	$619.0M	↓ 37.64%
Net Income	$143.4M	↑ 37.44%
Net Profit Margin	23.17%	↑ 12.66%

	FY23	Y/Y Change
Revenue	$289.2M	↓ 53.27%
Net Income	$-167.8M	↓ 217.03%
Net Profit Margin	-58.03%	↓ 81.2%

	FY24	Y/Y Change
Revenue	$283.5M	↓ 1.99%
Net Income	$-42.7M	↓ 74.55%
Net Profit Margin	-15.07%	↑ 42.96%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$64.5M	↓ 8.54%
Net Income	$-13.5M	↓ 89.5%
Net Profit Margin	-20.88%	↑ 160.88%

	Q2 FY24	Q/Q Change
Revenue	$71.0M	↑ 10.15%
Net Income	$-8.7M	↓ 35.3%
Net Profit Margin	-12.26%	↑ 8.62%

	Q3 FY24	Q/Q Change
Revenue	$71.7M	↑ 1.01%
Net Income	$-14.6M	↑ 68.17%
Net Profit Margin	-20.42%	↓ 8.16%

	Q4 FY24	Q/Q Change
Revenue	$76.2M	↑ 6.23%
Net Income	$-5.9M	↓ 59.8%
Net Profit Margin	-7.73%	↑ 12.69%

	Q1 FY25	Q/Q Change
Revenue	$73.5M	↓ 3.61%
Net Income	$-11.5M	↑ 95.82%
Net Profit Margin	-15.69%	↓ 7.96%

	Q2 FY25	Q/Q Change
Revenue	$81.8M	↑ 11.35%
Net Income	$-19.0M	↑ 64.41%
Net Profit Margin	-23.17%	↓ 7.48%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$18.4M	↑ 72.72%

	FY20	Y/Y Change
Profit	$331.9M	↑ 1701.78%

	FY21	Y/Y Change
Profit	$777.1M	↑ 134.12%

	FY22	Y/Y Change
Profit	$366.9M	↓ 52.78%

	FY23	Y/Y Change
Profit	$104.5M	↓ 71.53%

	FY24	Y/Y Change
Profit	$107.2M	↑ 2.64%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$20.1M	↓ 13.57%

	Q2 FY24	Q/Q Change
Profit	$24.5M	↑ 21.81%

	Q3 FY24	Q/Q Change
Profit	$26.8M	↑ 9.26%

	Q4 FY24	Q/Q Change
Profit	$31.8M	↑ 18.97%

	Q1 FY25	Q/Q Change
Profit	$28.3M	↓ 11.0%

	Q2 FY25	Q/Q Change
Profit	$34.4M	↑ 21.48%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$5.5M	↓ 917.33%
Investing Cash Flow	$-29.0M	↓ 3157.47%
Financing Cash Flow	$28.8M	↑ 191733.33%

	FY20	Y/Y Change
Operating Cash Flow	$140.6M	↑ 2448.99%
Investing Cash Flow	$-326.4M	↑ 1023.87%
Financing Cash Flow	$261.3M	↑ 807.91%

	FY21	Y/Y Change
Operating Cash Flow	$538.6M	↑ 282.98%
Investing Cash Flow	$-546.5M	↑ 67.43%
Financing Cash Flow	$85.4M	↓ 67.31%

	FY22	Y/Y Change
Operating Cash Flow	$253.5M	↓ 52.93%
Investing Cash Flow	$-261.3M	↓ 52.19%
Financing Cash Flow	$-77.1M	↓ 190.33%

	FY23	Y/Y Change
Operating Cash Flow	$27.0M	↓ 89.35%
Investing Cash Flow	$38.9M	↓ 114.89%
Financing Cash Flow	$-47.8M	↓ 38.05%

	FY24	Y/Y Change
Operating Cash Flow	$21.1M	↓ 22.01%
Investing Cash Flow	$-58.4M	↓ 250.01%
Financing Cash Flow	$-4.8M	↓ 89.86%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$7.3M	↓ 51.34%
Investing Cash Flow	$-47.2M	↓ 294.42%
Financing Cash Flow	$-2.8M	↓ 89.18%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$4.3M	↓ 41.03%
Investing Cash Flow	$7.3M	↓ 115.48%
Financing Cash Flow	$-1.1M	↓ 59.17%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-15.5M	↓ 461.94%
Investing Cash Flow	$9.0M	↑ 23.01%
Financing Cash Flow	$-567.0K	↓ 50.52%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$25.0M	↓ 261.31%
Investing Cash Flow	$-27.5M	↓ 405.56%
Financing Cash Flow	$-327.0K	↓ 42.33%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-4.4M	↓ 117.71%
Investing Cash Flow	$27.7M	↓ 201.0%
Financing Cash Flow	$-11.2M	↑ 3316.51%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-30.2M	↑ 580.91%
Investing Cash Flow	$53.4M	↑ 92.59%
Financing Cash Flow	$-2.6M	↓ 76.39%

Fulgent Genetics Technicals Summary

Sell

Neutral

Buy

Fulgent Genetics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Fulgent Genetics Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Fulgent Genetics Inc	19.77%	25.95%	-10.67%	-56.61%	-51.69%
Agilent Technologies Inc.	6.39%	-11.83%	-15.17%	-13.38%	21.68%
Idexx Laboratories, Inc.	24.95%	44.93%	30.96%	74.14%	70.6%
Thermo Fisher Scientific, Inc.	20.76%	-6.52%	-19.52%	-16.91%	16.26%
Danaher Corp.	12.16%	3.13%	-22.24%	-27.87%	2.43%
Iqvia Holdings Inc.	20.21%	-1.07%	-21.4%	-20.05%	19.31%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Fulgent Genetics Inc	7.49	NA	1.32	-0.35	-0.05	-0.04	NA	36.48
Agilent Technologies Inc.	29.36	29.36	1.75	5.58	0.19	0.08	0.01	21.61
Idexx Laboratories, Inc.	54.06	54.06	4.87	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.25	28.25	1.99	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	44.88	44.88	2.11	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	27.69	27.69	1.1	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Fulgent Genetics Inc	Buy	$666.4M	-51.69%	7.49	-16.83%
Agilent Technologies Inc.	Buy	$33.9B	21.68%	29.36	17.59%
Idexx Laboratories, Inc.	Buy	$52.1B	70.6%	54.06	24.41%
Thermo Fisher Scientific, Inc.	Buy	$184.7B	16.26%	28.25	15.24%
Danaher Corp.	Buy	$151.0B	2.43%	44.88	14.21%
Iqvia Holdings Inc.	Buy	$32.5B	19.31%	27.69	7.88%

About Fulgent Genetics Inc

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.

Organization	Fulgent Genetics
Employees	1313
CEO	Mr. Ming Hsieh
Industry	Health Services

Key Management of Fulgent Genetics Inc

Name	Title
Mr. Ming Hsieh	Chairman & CEO
Mr. Jian Xie	COO & President
Mr. Paul Kim CPA	Chief Financial Officer
Dr. Hanlin Gao D.A.B.M.G., FACMG, M.D., Ph.D.	Chief Scientific Officer & Lab Director
Ms. Natalie Prescott	General Counsel & Chief Privacy Officer
Ms. Doreen Ng	Vice President of Operations & Compliance
Mr. Jakub Sram	Vice President of Business Development & Sales
Ms. Ellen Tsui	Vice President of Human Resources
Mr. Brandon Perthuis	Chief Commercial Officer
Mr. Elias Nyankojo	Chief Information Security Officer

Important FAQs about investing in FLGT Stock from India :

What is Fulgent Genetics share price today?

Fulgent Genetics share price today is $21.65 as on August 18, 2025 at 11:40 PM IST. Fulgent Genetics share today touched a day high of $21.65 and a low of $21.45.

What is the 52 week high and 52 week low for Fulgent Genetics share?

Fulgent Genetics share touched a 52 week high of $23.99 and a 52 week low of $14.57. Fulgent Genetics stock price today, August 18, 2025 at 11:40 PM IST is trending at $21.65, lower by 9.74% versus the 52 week high.

How to invest in Fulgent Genetics Stock (FLGT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Fulgent Genetics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Fulgent Genetics Shares that will get you 0.0693 shares as per Fulgent Genetics share price of $21.65 per share as on August 18, 2025 at 11:40 PM IST.

What is the minimum amount required to buy Fulgent Genetics Stock (FLGT) from India?

Indian investors can start investing in Fulgent Genetics (FLGT) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Fulgent Genetics stock (as per the Rupee-Dollar exchange rate as on August 18, 2025). Based on Fulgent Genetics share’s latest price of $21.65 as on August 18, 2025 at 11:40 PM IST, you will get 0.4619 shares of Fulgent Genetics. Learn more about fractional shares .

What are the returns that Fulgent Genetics has given to Indian investors in the last 5 years?

Fulgent Genetics stock has given -51.69% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?